Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
M.D. Anderson Cancer Center |
---|---|
Information provided by: | M.D. Anderson Cancer Center |
ClinicalTrials.gov Identifier: | NCT00430872 |
Primary Objective:
1. To evaluate the psychometric properties of the MDASI-Spine in patients with tumors involving the spine or spinal cord.
Secondary Objective:
1. To describe the severity of commonly occurring symptoms experienced by persons with spine tumors.
Condition | Intervention |
---|---|
Spinal Cord Tumor |
Behavioral: Survey |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | Validation of the M.D. Anderson Symptom Inventory-Spine Tumor Module |
Estimated Enrollment: | 128 |
Study Start Date: | January 2007 |
Study Completion Date: | July 2008 |
Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
---|---|
1
Patients with a tumor on the spine or spinal cord.
|
Behavioral: Survey
Survey about the severity of certain symptoms lasting 10-15 minutes.
|
If you agree to take part in this study, you will complete the M. D. Anderson Symptom Inventory-Spine Tumor Module survey. This survey will ask you to rate the severity of certain symptoms you may have had in the last 24 hours on a scale of 0 (not present) to 10 (the most severe you can imagine). You will also be asked to rate how your symptoms get in the way of your daily activities using the same 0 to 10 scale. This survey should take about 10-15 minutes to complete.
Information regarding your clinical history (tumor type, location, treatment, and other medications) and demographic information (age, gender, ethnicity, religion, educational level, and marital status) will also be collected. This information will be used to evaluation whether there is an association between symptom severity and these factors.
Once you have completed the survey, your participation on this study will be over.
This is an investigational study. Up to 128 patients will take part in this study. All will be enrolled at M. D. Anderson.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Patients with a tumor on the spine or spinal cord.
Inclusion Criteria:
Exclusion Criteria:
United States, Texas | |
U.T. M.D. Anderson Cancer Center | |
Houston, Texas, United States, 77030 |
Principal Investigator: | Terri S. Armstrong, PhD | U.T.M.D. Anderson Cancer Center |
Responsible Party: | U.T.M.D. Anderson Cancer Center ( Terri S. Armstrong, PhD/Associate Professor ) |
Study ID Numbers: | 2006-0809 |
Study First Received: | February 1, 2007 |
Last Updated: | December 30, 2008 |
ClinicalTrials.gov Identifier: | NCT00430872 History of Changes |
Health Authority: | United States: Institutional Review Board |
Spinal Cord Tumor Intramedullary Spinal Cord Tumor Extramedullary Spinal Cord Tumor Symptoms Survey |
Spinal Cord Diseases Spinal Cord Neoplasm Central Nervous System Diseases |
Spinal Cord Neoplasms Central Nervous System Neoplasms Nervous System Neoplasms |
Neoplasms Neoplasms by Site Spinal Cord Diseases Nervous System Diseases |
Central Nervous System Diseases Spinal Cord Neoplasms Central Nervous System Neoplasms Nervous System Neoplasms |